Pro-Dex, Inc. (PDEX)
USD 45.73
(-5.61%)
USD 45.73
(-5.61%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 2.12 Million USD | -69.93% |
| 2023 | 7.07 Million USD | 54.72% |
| 2022 | 4.57 Million USD | 2.74% |
| 2021 | 4.45 Million USD | -27.19% |
| 2020 | 6.11 Million USD | 47.35% |
| 2019 | 4.14 Million USD | 155.89% |
| 2018 | 1.62 Million USD | -68.12% |
| 2017 | 5.08 Million USD | 518.49% |
| 2016 | 822 Thousand USD | 325.21% |
| 2015 | -365 Thousand USD | 25.2% |
| 2014 | -488 Thousand USD | 72.65% |
| 2013 | -1.78 Million USD | -103.65% |
| 2012 | -876 Thousand USD | -133.18% |
| 2011 | 2.64 Million USD | 188.95% |
| 2010 | -2.96 Million USD | -4.32% |
| 2009 | -2.84 Million USD | -997.48% |
| 2008 | 317 Thousand USD | -37.35% |
| 2007 | 506 Thousand USD | -38.81% |
| 2006 | 827 Thousand USD | -55.27% |
| 2005 | 1.84 Million USD | 65.09% |
| 2004 | 1.12 Million USD | 742.11% |
| 2003 | 133 Thousand USD | 108.49% |
| 2002 | -1.56 Million USD | -155.01% |
| 2001 | 2.84 Million USD | 84.75% |
| 2000 | 1.54 Million USD | 117.25% |
| 1999 | -8.93 Million USD | -2626.87% |
| 1998 | 353.56 Thousand USD | 122.1% |
| 1997 | -1.6 Million USD | -233.33% |
| 1996 | 1.2 Million USD | 300.0% |
| 1995 | 300 Thousand USD | -50.0% |
| 1994 | 600 Thousand USD | 500.0% |
| 1993 | 100 Thousand USD | -66.67% |
| 1992 | 300 Thousand USD | 50.0% |
| 1991 | 200 Thousand USD | -33.33% |
| 1990 | 300 Thousand USD | 160.0% |
| 1989 | -500 Thousand USD | 58.33% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 655 Thousand USD | 31.0% |
| 2024 Q2 | 500 Thousand USD | 181.3% |
| 2024 Q1 | -615 Thousand USD | -116.16% |
| 2024 FY | 2.12 Million USD | -69.93% |
| 2024 Q4 | 1.58 Million USD | 142.29% |
| 2023 Q2 | 879 Thousand USD | -18.31% |
| 2023 Q4 | 3.8 Million USD | 135.37% |
| 2023 Q1 | 1.07 Million USD | -23.42% |
| 2023 FY | 7.07 Million USD | 54.72% |
| 2023 Q3 | 1.61 Million USD | 83.96% |
| 2022 Q1 | 1.06 Million USD | 24.88% |
| 2022 Q4 | 1.4 Million USD | 204.11% |
| 2022 Q3 | 462 Thousand USD | -50.05% |
| 2022 Q2 | 925 Thousand USD | -13.06% |
| 2022 FY | 4.57 Million USD | 2.74% |
| 2021 Q1 | 1.26 Million USD | -50.31% |
| 2021 Q2 | 337 Thousand USD | -73.36% |
| 2021 Q4 | 852 Thousand USD | -57.29% |
| 2021 Q3 | 1.99 Million USD | 491.99% |
| 2021 FY | 4.45 Million USD | -27.19% |
| 2020 FY | 6.11 Million USD | 47.35% |
| 2020 Q3 | 1.21 Million USD | -2.88% |
| 2020 Q2 | 1.24 Million USD | 13.13% |
| 2020 Q1 | 1.1 Million USD | 24.32% |
| 2020 Q4 | 2.54 Million USD | 109.89% |
| 2019 Q3 | 732 Thousand USD | -37.91% |
| 2019 FY | 4.14 Million USD | 155.89% |
| 2019 Q4 | 888 Thousand USD | 21.31% |
| 2019 Q1 | 1.34 Million USD | 702.98% |
| 2019 Q2 | 1.17 Million USD | -12.6% |
| 2018 Q2 | 345 Thousand USD | -45.06% |
| 2018 Q4 | 168 Thousand USD | -65.0% |
| 2018 Q3 | 480 Thousand USD | 39.13% |
| 2018 FY | 1.62 Million USD | -68.12% |
| 2018 Q1 | 628 Thousand USD | -12.29% |
| 2017 Q3 | 888 Thousand USD | -72.2% |
| 2017 Q4 | 716 Thousand USD | -19.37% |
| 2017 FY | 5.08 Million USD | 518.49% |
| 2017 Q1 | 286 Thousand USD | 51.32% |
| 2017 Q2 | 3.19 Million USD | 1016.78% |
| 2016 FY | 822 Thousand USD | 325.21% |
| 2016 Q4 | 189 Thousand USD | -48.64% |
| 2016 Q2 | 391 Thousand USD | 412.8% |
| 2016 Q3 | 368 Thousand USD | -5.88% |
| 2016 Q1 | -125 Thousand USD | -271.23% |
| 2015 FY | -365 Thousand USD | 25.2% |
| 2015 Q1 | -170 Thousand USD | -808.33% |
| 2015 Q2 | -192 Thousand USD | -12.94% |
| 2015 Q4 | 73 Thousand USD | 196.05% |
| 2015 Q3 | -76 Thousand USD | 60.42% |
| 2014 FY | -488 Thousand USD | 72.65% |
| 2014 Q4 | 24 Thousand USD | 106.23% |
| 2014 Q3 | -385 Thousand USD | -13.91% |
| 2014 Q2 | -338 Thousand USD | -259.43% |
| 2014 Q1 | 212 Thousand USD | 131.55% |
| 2013 FY | -1.78 Million USD | -103.65% |
| 2013 Q3 | -747 Thousand USD | -114.66% |
| 2013 Q2 | -348 Thousand USD | -1947.06% |
| 2013 Q1 | -17 Thousand USD | 96.88% |
| 2013 Q4 | -672 Thousand USD | 10.04% |
| 2012 Q3 | -487 Thousand USD | -66.78% |
| 2012 FY | -876 Thousand USD | -133.18% |
| 2012 Q4 | -544 Thousand USD | -11.7% |
| 2012 Q2 | -292 Thousand USD | -165.47% |
| 2012 Q1 | 446 Thousand USD | -56.61% |
| 2011 FY | 2.64 Million USD | 188.95% |
| 2011 Q1 | 342 Thousand USD | 108.76% |
| 2011 Q2 | 401 Thousand USD | 17.25% |
| 2011 Q3 | 868 Thousand USD | 116.46% |
| 2011 Q4 | 1.02 Million USD | 18.43% |
| 2010 Q3 | 174 Thousand USD | -70.0% |
| 2010 Q4 | -3.9 Million USD | -2344.25% |
| 2010 Q2 | 580 Thousand USD | 216.94% |
| 2010 FY | -2.96 Million USD | -4.32% |
| 2010 Q1 | 183 Thousand USD | -9.41% |
| 2009 Q1 | -118 Thousand USD | 71.36% |
| 2009 Q2 | 81 Thousand USD | 168.64% |
| 2009 FY | -2.84 Million USD | -997.48% |
| 2009 Q3 | -3.01 Million USD | -3817.28% |
| 2009 Q4 | 202 Thousand USD | 106.71% |
| 2008 FY | 317 Thousand USD | -37.35% |
| 2008 Q2 | 305 Thousand USD | -6.44% |
| 2008 Q3 | 99 Thousand USD | -67.54% |
| 2008 Q4 | -412 Thousand USD | -516.16% |
| 2008 Q1 | 326 Thousand USD | 74.33% |
| 2007 Q4 | 187 Thousand USD | -13.43% |
| 2007 Q1 | 242 Thousand USD | 4.76% |
| 2007 FY | 506 Thousand USD | -38.81% |
| 2007 Q2 | -138 Thousand USD | -157.02% |
| 2007 Q3 | 216 Thousand USD | 256.52% |
| 2006 Q4 | 231 Thousand USD | 3750.0% |
| 2006 Q3 | 6000.00 USD | -98.17% |
| 2006 Q2 | 327 Thousand USD | 24.81% |
| 2006 Q1 | 262 Thousand USD | -71.77% |
| 2006 FY | 827 Thousand USD | -55.27% |
| 2005 FY | 1.84 Million USD | 65.09% |
| 2005 Q1 | 462 Thousand USD | 5.72% |
| 2005 Q2 | 183 Thousand USD | -60.39% |
| 2005 Q3 | 275 Thousand USD | 50.27% |
| 2005 Q4 | 928 Thousand USD | 237.45% |
| 2004 Q3 | 261 Thousand USD | 13.48% |
| 2004 Q2 | 230 Thousand USD | 19.17% |
| 2004 Q4 | 437 Thousand USD | 67.43% |
| 2004 FY | 1.12 Million USD | 742.11% |
| 2004 Q1 | 193 Thousand USD | 72.32% |
| 2003 Q1 | -6000.00 USD | 99.16% |
| 2003 FY | 133 Thousand USD | 108.49% |
| 2003 Q4 | 112 Thousand USD | 100.0% |
| 2003 Q3 | 56 Thousand USD | 293.1% |
| 2003 Q2 | -29 Thousand USD | -383.33% |
| 2002 Q3 | -337 Thousand USD | 33.53% |
| 2002 Q4 | -712 Thousand USD | -111.28% |
| 2002 FY | -1.56 Million USD | -155.01% |
| 2002 Q1 | -11 Thousand USD | -100.4% |
| 2002 Q2 | -507 Thousand USD | -4509.09% |
| 2001 Q2 | 36.43 Thousand USD | -91.44% |
| 2001 Q3 | -358 Thousand USD | -1082.71% |
| 2001 FY | 2.84 Million USD | 84.75% |
| 2001 Q4 | 2.74 Million USD | 866.2% |
| 2001 Q1 | 425.55 Thousand USD | 0.13% |
| 2000 Q3 | 311 Thousand USD | -55.57% |
| 2000 FY | 1.54 Million USD | 117.25% |
| 2000 Q4 | 425 Thousand USD | 36.66% |
| 2000 Q2 | 700 Thousand USD | 600.0% |
| 2000 Q1 | 100 Thousand USD | 101.49% |
| 1999 Q2 | -800 Thousand USD | -14.29% |
| 1999 Q4 | -6.73 Million USD | -862.0% |
| 1999 Q3 | -700 Thousand USD | 12.5% |
| 1999 Q1 | -700 Thousand USD | -184.04% |
| 1999 FY | -8.93 Million USD | -2626.87% |
| 1998 FY | 353.56 Thousand USD | 122.1% |
| 1998 Q1 | 400 Thousand USD | 100.0% |
| 1998 Q2 | 300 Thousand USD | -25.0% |
| 1998 Q3 | -100 Thousand USD | -133.33% |
| 1998 Q4 | -246.44 Thousand USD | -146.44% |
| 1997 Q4 | 200 Thousand USD | 116.67% |
| 1997 Q2 | -100 Thousand USD | 66.67% |
| 1997 Q1 | -300 Thousand USD | -200.0% |
| 1997 Q3 | -1.2 Million USD | -1100.0% |
| 1997 FY | -1.6 Million USD | -233.33% |
| 1996 Q1 | 300 Thousand USD | 400.0% |
| 1996 Q3 | 400 Thousand USD | 100.0% |
| 1996 FY | 1.2 Million USD | 300.0% |
| 1996 Q4 | 300 Thousand USD | -25.0% |
| 1996 Q2 | 200 Thousand USD | -33.33% |
| 1995 Q3 | - USD | -100.0% |
| 1995 Q4 | -100 Thousand USD | 0.0% |
| 1995 Q2 | 200 Thousand USD | 0.0% |
| 1995 Q1 | 200 Thousand USD | 100.0% |
| 1995 FY | 300 Thousand USD | -50.0% |
| 1994 Q2 | 300 Thousand USD | 50.0% |
| 1994 Q3 | - USD | -100.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 FY | 600 Thousand USD | 500.0% |
| 1994 Q1 | 200 Thousand USD | 200.0% |
| 1993 Q3 | 200 Thousand USD | 100.0% |
| 1993 FY | 100 Thousand USD | -66.67% |
| 1993 Q4 | -200 Thousand USD | -200.0% |
| 1993 Q1 | 100 Thousand USD | -50.0% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1992 FY | 300 Thousand USD | 50.0% |
| 1992 Q4 | 200 Thousand USD | 100.0% |
| 1992 Q1 | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 FY | 200 Thousand USD | -33.33% |
| 1991 Q3 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | 300 Thousand USD | 160.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q1 | - USD | 0.0% |
| 1989 Q2 | - USD | 0.0% |
| 1989 FY | -500 Thousand USD | 58.33% |
| 1989 Q3 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Akoya Biosciences, Inc. | -63.32 Million USD | 103.359% |
| AngioDynamics, Inc. | -184.34 Million USD | 101.154% |
| AtriCure, Inc. | -30.43 Million USD | 106.988% |
| Avinger, Inc. | -18.32 Million USD | 111.61% |
| Azenta, Inc. | -14.25 Million USD | 114.919% |
| BioLife Solutions, Inc. | -66.42 Million USD | 103.202% |
| The Cooper Companies, Inc. | 294.2 Million USD | 99.277% |
| Daxor Corporation | 280.64 Thousand USD | -657.91% |
| Ekso Bionics Holdings, Inc. | -15.19 Million USD | 113.995% |
| Femasys Inc. | -14.24 Million USD | 114.929% |
| GlucoTrack, Inc. | -7.09 Million USD | 129.97% |
| Harvard Bioscience, Inc. | -3.41 Million USD | 162.284% |
| Hologic, Inc. | 789.5 Million USD | 99.731% |
| ICU Medical, Inc. | -29.65 Million USD | 107.172% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 99.882% |
| KORU Medical Systems, Inc. | -13.74 Million USD | 115.479% |
| LeMaitre Vascular, Inc. | 30.1 Million USD | 92.935% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 131.921% |
| Innovative Eyewear, Inc. | -6.66 Million USD | 131.921% |
| Masimo Corporation | 81.5 Million USD | 97.39% |
| Microbot Medical Inc. | -10.74 Million USD | 119.804% |
| Meihua International Medical Technologies Co., Ltd. | 11.62 Million USD | 81.704% |
| Merit Medical Systems, Inc. | 94.41 Million USD | 97.747% |
| Nephros, Inc. | -1.57 Million USD | 235.048% |
| NovoCure Limited | -207.04 Million USD | 101.027% |
| NEXGEL, Inc. | -3.15 Million USD | 167.374% |
| NEXGEL, Inc. | -3.15 Million USD | 167.374% |
| Singular Genomics Systems, Inc. | -94.82 Million USD | 102.243% |
| OraSure Technologies, Inc. | 53.65 Million USD | 96.036% |
| Pulse Biosciences, Inc. | -42.21 Million USD | 105.039% |
| Predictive Oncology Inc. | -13.98 Million USD | 115.21% |
| Precision Optics Corporation, Inc. | -2.95 Million USD | 172.068% |
| QuidelOrtho Corporation | -10.1 Million USD | 121.059% |
| Repligen Corporation | 41.57 Million USD | 94.884% |
| Sanara MedTech Inc. | -4.3 Million USD | 149.428% |
| STAAR Surgical Company | 21.34 Million USD | 90.036% |
| Sharps Technology, Inc. | -9.84 Million USD | 121.612% |
| Utah Medical Products, Inc. | 16.63 Million USD | 87.214% |
| DENTSPLY SIRONA Inc. | -132 Million USD | 101.611% |
| Jin Medical International Ltd. | 2.87 Million USD | 26.1% |